These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6650125)

  • 41. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine.
    Hulsman JA; Rentmeester TW; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Radwanski E; Mojaverian P; Lin CC; Nezamis J
    Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma.
    Mazzucchelli I; Franco V; Fattore C; Marchiselli R; Perucca E; Gatti G
    Ther Drug Monit; 2007 Jun; 29(3):319-24. PubMed ID: 17529889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Monitoring therapy by analysis of the drug concentration of saliva].
    Bartels H; Günther E; Wallis S
    Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers.
    Incecayir T; Agabeyoglu I; Gucuyener K
    Arzneimittelforschung; 2007; 57(8):517-21. PubMed ID: 17915637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS).
    Kłys M; Rojek S; Bolechała F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(1):38-46. PubMed ID: 16154521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.
    Clemens PL; Cloyd JC; Kriel RL; Remmel RP
    Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants.
    Leclercq M; Mathieu O; Gomez E; Casellas C; Fenet H; Hillaire-Buys D
    Arch Environ Contam Toxicol; 2009 Apr; 56(3):408-15. PubMed ID: 18779941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of free level monitoring of antiepileptic drugs.
    Levy RH; Schmidt D
    Epilepsia; 1985; 26(3):199-205. PubMed ID: 3924585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.
    Vainionpää LK; Mikkonen K; Rättyä J; Knip M; Pakarinen AJ; Myllylä VV; Isojärvi JI
    Epilepsia; 2004 Mar; 45(3):197-203. PubMed ID: 15009219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of a LC/MS/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum.
    Paglia G; D'Apolito O; Garofalo D; Scarano C; Corso G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(2):153-9. PubMed ID: 17996501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical pharmacology and pharmacokinetics of oxcarbazepine.
    Lloyd P; Flesch G; Dieterle W
    Epilepsia; 1994; 35 Suppl 3():S10-3. PubMed ID: 8156973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacokinetic variability of oxcarbazepine in epileptic patients].
    Viola MS; Bercellini MA; Saidón P; Rubio MC
    Medicina (B Aires); 2000; 60(6):914-8. PubMed ID: 11436701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
    Theis JG; Sidhu J; Palmer J; Job S; Bullman J; Ascher J
    Neuropsychopharmacology; 2005 Dec; 30(12):2269-74. PubMed ID: 16052246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans.
    Almeida L; Soares-da-Silva P
    J Clin Pharmacol; 2004 Aug; 44(8):906-18. PubMed ID: 15286095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of saliva samples in monitoring carbamazepine concentrations in epileptic patients.
    Kristensen O; Larsen HF
    Acta Neurol Scand; 1980 Jun; 61(6):344-50. PubMed ID: 6998249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Artesi C; Xiao B; Perucca E; Di Perri R
    Acta Neurol Scand; 1994 Aug; 90(2):130-2. PubMed ID: 7801739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.
    Antunes NJ; van Dijkman SC; Lanchote VL; Wichert-Ana L; Coelho EB; Alexandre Junior V; Takayanagui OM; Tozatto E; van Hasselt JGC; Della Pasqua O
    Eur J Pharm Sci; 2017 Nov; 109S():S116-S123. PubMed ID: 28528287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine.
    Keränen T; Sorri A; Moilanen E; Ylitalo P
    Arzneimittelforschung; 2010; 60(7):421-6. PubMed ID: 20712131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tears as the best practical indicator of the unbound fraction of an anticonvulsant drug.
    Monaco F; Mutani R; Mastropaolo C; Tondi M
    Epilepsia; 1979 Dec; 20(6):705-10. PubMed ID: 499116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.